Market Closed -
Nyse
04:00:01 2024-05-10 pm EDT
|
5-day change
|
1st Jan Change
|
4.65
USD
|
-2.31%
|
|
-0.64%
|
-37.78%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,248
|
2,756
|
3,939
|
3,564
|
3,235
|
5,000
|
-
|
-
|
Enterprise Value (EV)
1 |
1,386
|
2,981
|
4,067
|
3,617
|
3,299
|
5,448
|
5,418
|
5,542
|
P/E ratio
|
25.1
x
|
-145
x
|
7,396
x
|
14.6
x
|
4.73
x
|
20
x
|
9.96
x
|
4.84
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.21
x
|
9.56
x
|
9.37
x
|
4.38
x
|
3.67
x
|
3.99
x
|
2.83
x
|
1.96
x
|
EV / Revenue
|
3.57
x
|
10.3
x
|
9.67
x
|
4.45
x
|
3.74
x
|
4.35
x
|
3.06
x
|
2.17
x
|
EV / EBITDA
|
13.9
x
|
134
x
|
58.5
x
|
9.86
x
|
6.57
x
|
11.1
x
|
6.78
x
|
3.79
x
|
EV / FCF
|
-11
x
|
-25.3
x
|
-38.5
x
|
30.7
x
|
-111
x
|
-28.7
x
|
-17.9
x
|
-40.2
x
|
FCF Yield
|
-9.11%
|
-3.95%
|
-2.59%
|
3.26%
|
-0.9%
|
-3.49%
|
-5.57%
|
-2.49%
|
Price to Book
|
2.29
x
|
4.87
x
|
5.48
x
|
2.78
x
|
0.68
x
|
0.87
x
|
0.75
x
|
0.7
x
|
Nbr of stocks (in thousands)
|
351,230
|
352,004
|
388,749
|
431,573
|
432,889
|
1,075,190
|
-
|
-
|
Reference price
2 |
3.554
|
7.830
|
10.13
|
8.259
|
7.473
|
4.650
|
4.650
|
4.650
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/14/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
388.4
|
288.2
|
420.4
|
813.2
|
882.5
|
1,253
|
1,770
|
2,553
|
EBITDA
1 |
99.8
|
22.3
|
69.5
|
366.7
|
502.5
|
490.6
|
798.8
|
1,463
|
EBIT
1 |
78.9
|
-2.7
|
44.4
|
339
|
472.9
|
360.3
|
651.3
|
1,244
|
Operating Margin
|
20.31%
|
-0.94%
|
10.56%
|
41.69%
|
53.59%
|
28.76%
|
36.81%
|
48.72%
|
Earnings before Tax (EBT)
1 |
57.8
|
-25.4
|
23.9
|
335.4
|
389
|
326.2
|
612.4
|
1,092
|
Net income
1 |
50.2
|
-18.9
|
0.6
|
273.5
|
330.1
|
247.1
|
478.1
|
1,077
|
Net margin
|
12.92%
|
-6.56%
|
0.14%
|
33.63%
|
37.41%
|
19.72%
|
27.02%
|
42.18%
|
EPS
2 |
0.1413
|
-0.0540
|
0.001370
|
0.5652
|
1.580
|
0.2325
|
0.4667
|
0.9600
|
Free Cash Flow
1 |
-126.2
|
-117.7
|
-105.5
|
117.8
|
-29.8
|
-189.9
|
-301.9
|
-138
|
FCF margin
|
-32.49%
|
-40.84%
|
-25.1%
|
14.49%
|
-3.38%
|
-15.16%
|
-17.06%
|
-5.41%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
32.12%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
43.07%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/14/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
103.6
|
122.9
|
143.5
|
218.7
|
231.6
|
219.4
|
253.5
|
235.8
|
211.4
|
181.8
|
261.2
|
286.7
|
337
|
364.3
|
383.4
|
EBITDA
1 |
14.9
|
27.5
|
53.3
|
95
|
110.8
|
107.6
|
157.4
|
134.5
|
119.7
|
90.9
|
108.8
|
104
|
125
|
145.6
|
160.6
|
EBIT
1 |
8.7
|
21.1
|
46.9
|
88.6
|
104.2
|
99.3
|
150.6
|
127.5
|
112
|
82.8
|
91.6
|
88.2
|
103.8
|
123.6
|
122.1
|
Operating Margin
|
8.4%
|
17.17%
|
32.68%
|
40.51%
|
44.99%
|
45.26%
|
59.41%
|
54.07%
|
52.98%
|
45.54%
|
35.07%
|
30.76%
|
30.81%
|
33.93%
|
31.84%
|
Earnings before Tax (EBT)
1 |
2.8
|
17
|
57.9
|
90.2
|
99.1
|
88.2
|
138.7
|
104.8
|
96.7
|
48.8
|
73.7
|
74.1
|
79.7
|
92.2
|
120
|
Net income
1 |
-12.6
|
7.5
|
53.2
|
60
|
77.6
|
82.7
|
114.8
|
90.2
|
87.4
|
37.7
|
15.6
|
65.35
|
78.45
|
94.7
|
87.55
|
Net margin
|
-12.16%
|
6.1%
|
37.07%
|
27.43%
|
33.51%
|
37.69%
|
45.29%
|
38.25%
|
41.34%
|
20.74%
|
5.97%
|
22.79%
|
23.28%
|
25.99%
|
22.83%
|
EPS
2 |
-0.0332
|
0.0166
|
0.1164
|
0.1288
|
0.1538
|
0.1621
|
0.2286
|
0.1787
|
0.1746
|
0.1800
|
0.0100
|
0.0550
|
0.0750
|
0.1000
|
0.0700
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/4/21
|
2/17/22
|
5/3/22
|
8/2/22
|
11/1/22
|
2/14/23
|
5/2/23
|
8/3/23
|
10/31/23
|
2/22/24
|
5/7/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
138
|
225
|
127
|
52.9
|
64.4
|
448
|
418
|
542
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.381
x
|
10.09
x
|
1.833
x
|
0.1443
x
|
0.1282
x
|
0.9138
x
|
0.5236
x
|
0.3703
x
|
Free Cash Flow
1 |
-126
|
-118
|
-106
|
118
|
-29.8
|
-190
|
-302
|
-138
|
ROE (net income / shareholders' equity)
|
9.71%
|
-2.65%
|
4.87%
|
24.4%
|
17.7%
|
2.74%
|
4.45%
|
8.33%
|
ROA (Net income/ Total Assets)
|
6.62%
|
-2.1%
|
0.06%
|
16.7%
|
12.4%
|
3%
|
6.6%
|
10.4%
|
Assets
1 |
757.9
|
898.2
|
1,070
|
1,638
|
2,652
|
8,237
|
7,243
|
10,403
|
Book Value Per Share
2 |
1.550
|
1.610
|
1.850
|
2.970
|
10.90
|
5.360
|
6.180
|
6.640
|
Cash Flow per Share
2 |
0.1600
|
0.0200
|
0.0600
|
0.9400
|
1.420
|
0.3200
|
0.4400
|
0.6500
|
Capex
1 |
189
|
124
|
132
|
337
|
327
|
613
|
710
|
608
|
Capex / Sales
|
48.66%
|
43.03%
|
31.37%
|
41.43%
|
37.07%
|
48.96%
|
40.1%
|
23.81%
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/14/23
|
2/22/24
|
-
|
-
|
-
|
Last Close Price
4.65
USD Average target price
8.15
USD Spread / Average Target +75.26% Consensus |
1st Jan change
|
Capi.
|
---|
| -37.78% | 5B | | +17.73% | 66.69B | | +1.61% | 49.2B | | +16.33% | 41.24B | | +18.68% | 25.89B | | +12.78% | 19.81B | | -21.87% | 15.86B | | -10.29% | 15.23B | | +2.32% | 15.35B | | -22.30% | 13.36B |
Other Specialty Chemicals
|